Pharmacovigilance in China: Evolution and future challenges-Reference-Cited by-同舟云学术

Pharmacovigilance in China: Evolution and future challenges

Published:2022-03-16 Issue:2 Volume:89 Page:510-522
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Song Haibo¹²,Pei Xiaojing³,Liu Zuoxiang⁴,Shen Chuanyong¹²,Sun Jun⁵,Liu Yuqin⁶,Zhou Lingyun⁷,Sun Feng⁴^ORCID,Xiao Xiaohe⁸

Affiliation:

1. National Center for ADR Monitoring Beijing China

2. NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance Beijing China

3. Center for Drug Evaluation, NMPA Beijing China

4. Department of Epidemiology and Biostatistics, School of Public Health Peking University Beijing China

5. Center for Evaluation, Jiangsu Medical Products Administration Nanjing Jiangsu China

6. Gansu Center for Drug and Medical Devices Adverse Reaction Monitoring Lanzhou Gansu China

7. Lingyun Zhou, Sanofi (China) Investment Co., Ltd, Shanghai Branch Shanghai China

8. China Military Institute of Chinese Medicine Fifth Medical Center of Chinese PLA General Hospital Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15277

Reference91 articles.

1. Standing Committee of the National People's Congress.Medicinal Product Administration Law of the People's Republic of China.2019Revision. Available athttp://www.gov.cn/banshi/2005-08/01/content_18993.htm. (last accessed 2 Oct 2021).

2. WHO.The importance of pharmacovigilance. Available athttps://apps.who.int/iris/bitstream/handle/10665/42493/a75646.pdf. (last accessed 2 Oct 2021).

3. Evaluation of FDA safety-related drug label changes in 2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using twitter;Journal of Affective Disorders;2024-01

2. Insights into enterovirus a-71 antiviral development: from natural sources to synthetic nanoparticles;Archives of Microbiology;2023-09-21

3. Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China;Expert Opinion on Drug Safety;2023-03-21

4. Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey;BMC Health Services Research;2023-02-14

5. Quo vadis (where are you going) pharmacovigilance?;British Journal of Clinical Pharmacology;2022-11-17